International Differences Between Cosmetics and Drugs

Cosmetics or Drugs? International differences that impact FDA import compliance banner.

For cosmetic importers and beauty brands selling internationally, one of the biggest regulatory challenges is understanding that the definition of a “cosmetic” is not the same in every country. A product considered a cosmetic in one market may be regulated as a drug, over-the-counter medication, or even a medical device in another. These differences can significantly impact labeling requirements, ingredient approvals, facility registrations, testing obligations, and import compliance.

According to the FDA, products imported into the United States must comply with the same laws and regulations as products manufactured domestically. Imported cosmetics that appear to be adulterated or misbranded may be refused entry into the U.S. by the FDA and U.S. Customs and Border Protection (CBP).

In the United States, the FDA defines a cosmetic as a product intended for cleansing, beautifying, promoting attractiveness, or altering appearance. Drugs, however, are products intended to diagnose, cure, mitigate, treat, or prevent disease, or affect the structure or function of the body.

This distinction becomes especially important when products make claims related to:

  • Acne treatment
  • Anti-aging effects
  • Skin lightening
  • Hair regrowth
  • Sunscreen protection
  • Cell regeneration
  • Therapeutic or aromatherapy benefits

Under FDA rules, these types of claims may cause a cosmetic product to also be classified as a drug. Some products can legally be both a cosmetic and a drug in the United States, such as anti-dandruff shampoos, fluoride toothpaste, antiperspirants, or moisturizers with sunscreen claims. 

One of the most important issues for importers is that regulatory classifications vary widely across countries. The FDA specifically notes that some products regulated as cosmetics in Europe are regulated as drugs in the United States. Sunscreens are one of the most common examples. 

International differences may include:

  • Product classification standards
  • Approved or prohibited ingredients
  • Color additive restrictions
  • Registration requirements
  • Product testing obligations
  • Labeling rules
  • Claims allowed on packaging and marketing materials

For example, certain anti-aging or skin-brightening products sold freely as cosmetics in Asia or Europe may trigger drug classification in the United States because of the claims used in advertising or labeling. Likewise, “cosmeceutical” is a common marketing term internationally, but the FDA does not officially recognize “cosmeceuticals” as a legal product category. Under U.S. law, a product is considered a cosmetic, a drug, or both.

Why This Matters for Importers

Many cosmetic import issues arise not because of unsafe products, but because businesses fail to understand how the FDA interprets product claims and intended use. Even phrases on websites, social media ads, influencer campaigns, or product packaging can affect how the FDA classifies a product.

Importers should carefully review:

  1. Product claims and advertising language
  2. Ingredient compliance with U.S. standards
  3. Labeling and INCI requirements
  4. Whether the product could be classified as a drug
  5. Registration and listing obligations under MoCRA

Products that appear to violate FDA regulations may be detained, refused entry, or placed on Import Alert. FDA monitoring has increased in recent years, especially following the passage of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), which expanded FDA oversight of cosmetic manufacturing facilities and product listings.

A Growing Need for Global Regulatory Strategy

As beauty brands continue expanding across international markets, regulatory alignment is becoming more important than ever. Companies can no longer assume that a product approved in one country will automatically meet U.S. requirements.

Businesses importing cosmetics into the United States should work closely with regulatory experts, customs brokers, and qualified manufacturers to ensure products comply with FDA definitions, labeling standards, and marketing claim restrictions before entering the market. A proactive compliance strategy can help reduce costly shipment delays, product detentions, and enforcement actions while building long-term trust with retailers and consumers.

Back to blog